Global Cardio-Oncology Summit 2025: Key Insights and Takeaways

64 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
In this video, we dive into the highlights of the Global Cardio-Oncology Summit 2025, an international conference focused on advancing the field of cardio-oncology. Dr. Maria Sol Andres, a Clinical Research Fellow, shares her key takeaways.
Session 2: Dr. Andres discusses the potential of rhythmic mechanical stimulation to reduce tumor size, the role of ferroptosis in cardiotoxicity, and the importance of avoiding IV iron for patients receiving anthracyclines.
Keynote Lecture by Dr. Ruth Plummer: Dr. Plummer emphasizes the importance of finding the optimal dose, continuous cardiac monitoring, and tracking and learning from toxicities. She also highlights the latest developments in cancer treatment, including antibody-drug conjugates, immunotherapy, and genomic profiling.
Primary Care in Cardio-Oncology: Dr. Siva Tharshini Ramalingam stresses the role of primary care physicians in early recognition of side effects and the need for education. She inspires us to become agents of change in the field.
Cardio-Oncology in Africa: Presenters from Algeria, Kenya, Ghana, and South Africa discuss the challenges and opportunities in Africa, including the transition to long-term CVD and cancer care, limited resources, and the need for standardized programs and specialist training.
Venous Thromboembolism in Cancer Patients: Dr. Sebastian Szmit presents the API-CAT trial, which shows the non-inferiority of extended anticoagulation with a reduced dose of Apixaban in preventing recurrent VTE, a significant step forward in personalized care.
Join us as we explore these insights and discuss the future of cardio-oncology.
Categoria
Cardiology
Commenta per primo questo video.

Prossimo